Zimmer Biomet Q1 net sales hit $1.97B amid declines in the Americas: 5 things to know

Written by Laura Dyrda | April 26, 2019 | Print  |

Zimmer Biomet reported net sales at $1.97 billion for the first quarter of 2019, a 0.7 percent increase.


Five things to know:

1. The company reported a 1.2 percent decline in sales in the Americas, hitting $1.2 billion. The company also reported a 6.6 percent sales decline in the EMEA and 1.4 percent sales increase in the Asia Pacific.

2. Knee sales were down 2.7 percent in the quarter, hitting $694 million overall. Knee sales in the Americas dropped nearly 2 percent to $409 million.

3. Hip sales were relatively flat in the Americas, dropping 0.3 percent to $247 million. Overall, hip sales were down 1.6 percent to $484 million.

4. Spine and craniomaxillofacial sales were flat at $183 million for the quarter.

5. In the first quarter, Zimmer Biomet paid down $110 million of debt and plans to use most of its $284 million cash flow to continue decreasing debt throughout the year.

More articles on orthopedic devices:
Stryker Q1 spine sales up 38.6% in US after K2M acquisition: 6 things to know
12 device makers prepare pitches for judgets from Medtronic, DePUy Synthes & more
Fitch: 5 trends to watch in device company M&A

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months